Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...

Ramesh Swaminathan, Executive Director and CFO of Lupin, says India’s weight-loss drug market could reach $1 billion, and ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

Three new Cochrane reviews find evidence that GLP-1 drugs lead to clinically meaningful weight loss, though industry-funded ...

A new deal with major drugmakers, unveiled by U.S. President Donald Trump on Thursday, aims to expand coverage and cut prices ...

Obesity products gain momentum in India and globally as multinationals leverage smart pricing and collaborations amidst ...

Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...

New clinician-guided program blends medical science, microdosing, and 24/7 support to make advanced weight loss and wellness ...

The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...

Savannah Chrisley shared that she plans to begin using a GLP-1 medication to help her lose 25 pounds after previously trying ...

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...

Investors got to hear Novo Nordisk’s side of the Metsera bidding war drama for the first time on Wednesday, as the company ...